1. Home
  2. EDSA vs IVDA Comparison

EDSA vs IVDA Comparison

Compare EDSA & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • IVDA
  • Stock Information
  • Founded
  • EDSA 2015
  • IVDA 2003
  • Country
  • EDSA Canada
  • IVDA United States
  • Employees
  • EDSA N/A
  • IVDA N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • EDSA Health Care
  • IVDA Technology
  • Exchange
  • EDSA Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • EDSA 6.2M
  • IVDA 6.7M
  • IPO Year
  • EDSA N/A
  • IVDA N/A
  • Fundamental
  • Price
  • EDSA $2.03
  • IVDA $1.92
  • Analyst Decision
  • EDSA Strong Buy
  • IVDA
  • Analyst Count
  • EDSA 1
  • IVDA 0
  • Target Price
  • EDSA $21.00
  • IVDA N/A
  • AVG Volume (30 Days)
  • EDSA 14.5K
  • IVDA 57.7K
  • Earning Date
  • EDSA 05-14-2025
  • IVDA 05-13-2025
  • Dividend Yield
  • EDSA N/A
  • IVDA N/A
  • EPS Growth
  • EDSA N/A
  • IVDA N/A
  • EPS
  • EDSA N/A
  • IVDA N/A
  • Revenue
  • EDSA N/A
  • IVDA $7,148,449.00
  • Revenue This Year
  • EDSA N/A
  • IVDA $340.48
  • Revenue Next Year
  • EDSA N/A
  • IVDA N/A
  • P/E Ratio
  • EDSA N/A
  • IVDA N/A
  • Revenue Growth
  • EDSA N/A
  • IVDA 54.15
  • 52 Week Low
  • EDSA $1.55
  • IVDA $1.27
  • 52 Week High
  • EDSA $5.59
  • IVDA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 36.85
  • IVDA 37.44
  • Support Level
  • EDSA $1.99
  • IVDA $1.91
  • Resistance Level
  • EDSA $2.14
  • IVDA $2.38
  • Average True Range (ATR)
  • EDSA 0.11
  • IVDA 0.20
  • MACD
  • EDSA -0.03
  • IVDA -0.03
  • Stochastic Oscillator
  • EDSA 21.28
  • IVDA 6.67

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: